rs520354 — APOB APOB IVS6+360

APOB IVS6+360 — A Biliary Risk Signal Hidden in Plain Sight

Apolipoprotein B (ApoB) is far more than a cardiovascular protein. While ApoB-100 is best known as the structural backbone of LDL particles¹¹ LDL particles
each LDL particle carries exactly one ApoB-100 molecule, making ApoB a direct count of atherogenic particles, ApoB also plays a central role in bile acid metabolism and biliary lipid secretion. The liver exports cholesterol into bile via ABCG5/G8 transporters, but the hepatic lipid pools that feed bile production are regulated upstream by ApoB-containing lipoprotein trafficking. Variants that alter APOB regulation or expression can therefore shift biliary lipid balance — with consequences that extend beyond the arteries to the bile ducts and gallbladder.

The rs520354 variant sits 360 nucleotides into intron 6 of APOB (IVS6+360), deep within a non-coding region. It does not change any amino acid. Yet a large population-based study in China identified a striking sex-specific association: men carrying the A allele — the more common allele globally — faced roughly twice the risk of extrahepatic bile duct cancer compared to men carrying only G alleles.

The Mechanism

Because rs520354 is intronic, it does not alter the ApoB protein directly. Intronic variants can influence phenotype through several routes: altered pre-mRNA splicing²² pre-mRNA splicing
changes in exon inclusion/exclusion alter the final protein produced, creation or disruption of intronic regulatory elements, or linkage disequilibrium with a nearby causal variant in the same haplotype block. The IVS6+360 region falls within an intronic stretch with predicted regulatory motifs, and the A-allele haplotype (tagging the T allele in coding-strand notation) may tag a regulatory change that subtly shifts hepatic ApoB expression or biliary lipid composition.

Sex-specificity suggests hormonal interaction. Estrogen stimulates biliary cholesterol secretion and can raise the ratio of cholesterol-to-bile-salt in bile — a lithogenic³³ lithogenic
bile that tends to form gallstones because of high cholesterol saturation relative to bile acids and phospholipids index that promotes gallstone formation. In men, where estrogen is absent as a dominant modulator, any genetic shift in ApoB-mediated hepatic lipid handling may unmask differently than in women, where estrogen effects dominate biliary lipid composition. The APOB haplotype T-T (combining IVS6+360 and EX4+56 coding-strand T alleles) showed an even stronger bile duct cancer association (OR 1.6, 95% CI 1.1–2.3), consistent with haplotype effects in the same regulatory region.

The Evidence

The primary evidence comes from a 2008 population-based case-control study⁴⁴ 2008 population-based case-control study
Andreotti G et al., Cancer Epidemiol Biomarkers Prev, 17(3):525-34 conducted in Shanghai, China, comparing 235 gallbladder cancer cases, 125 extrahepatic bile duct cancer cases, 46 ampullary cancer cases, and 880 biliary stone cases against 779 population controls. Male carriers of the IVS6+360 T allele (A allele on the plus strand) had an odds ratio of 2.0 (95% CI 1.2–3.4) for bile duct cancer. This sex-specific association was not significant in women, and there was no significant association with gallbladder cancer or biliary stones overall, though the bile duct cancer finding was replicated when the full APOB haplotype was included.

A companion 2009 lipid study⁵⁵ 2009 lipid study
Andreotti G et al., Eur J Epidemiol, 24(12):763-74 examined APOB variants and serum lipid levels in 799 healthy Chinese residents and did not find rs520354 to be significantly associated with total cholesterol, LDL, or ApoB levels — suggesting this variant's primary effect in the biliary context is independent of gross changes in circulating lipids.

The evidence level is moderate: this is a single large case-control study with a biologically plausible sex-specific effect, but the finding requires replication in non-Chinese populations. The intronic mechanism remains hypothetical. ClinVar classifies this variant as benign in the context of hereditary lipid disorders, consistent with its lack of effect on serum lipids — the biliary cancer risk signal is a distinct phenotype not captured in that classification.

Practical Actions

For men carrying the A allele (AA or AG genotype), the actionable implication is heightened awareness of biliary tract health. The elevated risk is for extrahepatic bile duct cancer specifically — a relatively uncommon malignancy but one with poor prognosis when detected late. Men with this genotype who also have other biliary risk factors (gallstones, primary sclerosing cholangitis, chronic biliary infection, obesity, or heavy alcohol use) face a compounded risk that warrants proactive monitoring. Dietary modification that reduces biliary cholesterol saturation — specifically limiting dietary cholesterol and increasing bile acid–binding fiber — may reduce lithogenic stress on the bile ducts regardless of cancer risk.

Interactions

The IVS6+360 A allele appears to act as part of an APOB haplotype with the EX4+56 C>T variant. Carriers of the full T-T haplotype (both variants on the coding strand) had stronger bile duct cancer associations than IVS6+360 alone — suggesting additive effects within the same gene. The related rs693⁶⁶ rs693
APOB XbaI, a synonymous exon 26 variant with well-established effects on LDL particle number and ApoB levels represents a second independent functional locus in APOB with cardiovascular rather than biliary effects; the two should not be confused. APOE variants (particularly APOE rs440446) showed even stronger sex-specific biliary cancer associations in the same Shanghai study — suggesting a broader pattern of ApoB pathway variants influencing biliary tract cancer risk through partially overlapping mechanisms.